{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:58:33Z","timestamp":1790546313163,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005064","name":"Hebei Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["20200040"],"award-info":[{"award-number":["20200040"]}],"id":[{"id":"10.13039\/501100005064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37091","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T14:05:49Z","timestamp":1724853949000},"page":"e37091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between TIMP1 polymorphism and female neuromyelitis optica spectrum disorder in Chinese population"],"prefix":"10.1016","volume":"10","author":[{"given":"Hongjing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7901-8427","authenticated-orcid":false,"given":"Ruoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2024.e37091_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37091_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","article-title":"Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients","volume":"254","author":"Saiz","year":"2007","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37091_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2024.e37091_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e37091_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e37091_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2051-5960-2-48","article-title":"Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury","volume":"2","author":"Asavapanumas","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37091_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41401-020-0409-3","article-title":"Icariside II attenuates cerebral ischemia\/reperfusion-induced blood-brain barrier dysfunction in rats via regulating the balance of MMP9\/TIMP1","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37091_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12264-015-1552-6","article-title":"Experimental models of neuromyelitis optica: current status, challenges and future directions","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.heliyon.2024.e37091_bib9","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/acn3.50905","article-title":"GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica","volume":"6","author":"Shimizu","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e37091_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.04.009","article-title":"Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier","volume":"236","author":"Hosokawa","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37091_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","article-title":"Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica","volume":"85","author":"Tasaki","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37091_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/1352458516672015","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption","volume":"23","author":"Uchida","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.heliyon.2024.e37091_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e37091_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101438","article-title":"IRAK1 polymorphisms are associated with susceptibility to neuromyelitis optica spectrum disorder","volume":"37","author":"Shi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37091_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/bmm-2018-0169","article-title":"Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients","volume":"13","author":"Vira","year":"2019","journal-title":"Biomarkers Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37091_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00207454.2013.823604","article-title":"TIMP-1 polymorphisms in a Chinese Han population with intracerebral hemorrhage","volume":"124","author":"Wang","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37091_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/968267","article-title":"The \u03b1(1)AT and TIMP-1 gene polymorphism in the development of asthma","volume":"2012","author":"Kumar","year":"2012","journal-title":"Comp. Funct. Genom."},{"key":"10.1016\/j.heliyon.2024.e37091_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.humimm.2012.07.040","article-title":"Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients","volume":"73","author":"Skarmoutsou","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37091_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13018-014-0108-1","article-title":"Genetic susceptibility of early aseptic loosening after total hip arthroplasty: the influence of TIMP-1 gene polymorphism on Chinese Han population","volume":"9","author":"Pan","year":"2014","journal-title":"J. Orthop. Surg. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37091_bib20","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc12739","article-title":"The 372 T\/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis","volume":"17","author":"Lorente","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e37091_bib21","first-page":"155","article-title":"Association of tissue inhibitor of metalloproteinase-1 genotypes with lung cancer risk in taiwan","volume":"36","author":"Lai","year":"2016","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37091_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0009-8981(87)90250-6","article-title":"Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system","volume":"163","author":"Reiber","year":"1987","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37091_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37091_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","article-title":"SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e37091_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.maturitas.2018.11.018","article-title":"Association between tissue inhibitor of metalloproteinase (TIMP) genetic polymorphisms and primary ovarian insufficiency (POI)","volume":"120","author":"An","year":"2019","journal-title":"Maturitas"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e37091_bib26","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3748\/wjg.v13.i21.2960","article-title":"Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease","volume":"13","author":"Meijer","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37091_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/cc13037","article-title":"The 372 T\/C genetic polymorphism of TIMP-1 as a biomarker of mortality in patients with sepsis","volume":"17","author":"Lorente","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2024.e37091_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.18071\/isz.74.0050","article-title":"Matrix metalloproteinases and their tissue inhibitors in relapsing remitting multiple sclerosis: possible markers and treatment agents","volume":"74","author":"Sanli","year":"2021","journal-title":"Ideggyogyaszati Szle."},{"key":"10.1016\/j.heliyon.2024.e37091_bib30","article-title":"Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis","volume":"71","author":"Pyka-Fosciak","year":"2020","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e37091_bib31","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.heliyon.2024.e37091_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/124.3.493","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica","volume":"124","author":"Mandler","year":"2001","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37091_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094318","article-title":"Association of sepsis-related mortality with early increase of TIMP-1\/MMP-9 ratio","volume":"9","author":"Lorente","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37091_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.braindev.2019.11.010","article-title":"Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels in autoimmune encephalitis","volume":"42","author":"Matsuura","year":"2020","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37091_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1191\/1352458505ms1193oa","article-title":"Serum MMP-9\/TIMP-1 and MMP-2\/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment","volume":"11","author":"Avolio","year":"2005","journal-title":"Mult. Scler."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:35:32Z","timestamp":1790544932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024131222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024131222"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37091","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between TIMP1 polymorphism and female neuromyelitis optica spectrum disorder in Chinese population","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37091"}}